Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Onconetix (J4T2) Stock Price & Analysis

0 Followers

J4T2 Stock Chart & Stats

€119,850.00€0.00(0.00%)
At close: 5:30 PM GMT+1
No data to display
Day’s Range
EUR 119,850.00 - EUR 119,850.00
52-Week Range
EUR 119,850.00 - EUR 119,850.00
Previous Close
EUR 119,850.00
Volume
N/A
Average Volume (3M)
0
Market Cap
EUR 3.65M
Enterprise Value
-EUR 3.09T
Total Cash (Recent Filing)
EUR 5.94M
Total Debt (Recent Filing)
EUR 187.13K
Price to Earnings (P/E)
―
Beta
0.00
Next Earnings
N/A
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Growth Potential

Licensing proprietary technologies to other firms offers a scalable revenue stream, potentially increasing market penetration and financial stability over time.

Strategic Partnerships

Collaborations with larger firms can enhance product development and market reach, providing shared revenue opportunities and access to broader resources.

Innovative Product Portfolio

Onconetix's focus on advanced cancer diagnostics and personalized therapeutics positions it well in the biotech industry, leveraging technology for improved patient outcomes.

Bears Say

High Operating Losses

Significant operating losses reflect inefficiencies and financial strain, challenging the company's ability to achieve profitability and necessitating cost management.

Strained Cash Flows

Negative operating cash flow suggests difficulties in covering operational expenses, which can hinder growth initiatives and necessitate external financing.

Negative Profit Margins

Persistent negative profit margins indicate ongoing financial challenges, potentially limiting reinvestment capabilities and affecting long-term viability.

J4T2 FAQ

What was Onconetix’s price range in the past 12 months?
Onconetix lowest stock price was €119850.00 and its highest was €119850.00 in the past 12 months.
What is Onconetix’s market cap?
Onconetix’s market cap is €3.65M.
When is Onconetix’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Onconetix overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Onconetix pay dividends?
Onconetix does not currently pay dividends.
What is Onconetix’s EPS estimate?
Onconetix’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Onconetix have?
Onconetix has 588,677 shares outstanding.
Which hedge fund is a major shareholder of Onconetix?
Currently, no hedge funds are holding shares in DE:J4T2
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology